0,948  0,004  Apoptosis agonist
0,924  0,003  Chemopreventive
0,923  0,004  Transcription factor NF kappa B inhibitor
0,873  0,003  Caspase 3 stimulant
0,857  0,009  Antiinflammatory
0,847  0,004  Bone diseases treatment
0,840  0,004  Lipoprotein disorders treatment
0,837  0,003  Antineoplastic (liver cancer)
0,827  0,005  Atherosclerosis treatment
0,824  0,004  Antiosteoporotic
0,823  0,008  CYP3A4 substrate
0,821  0,008  Antineoplastic (breast cancer)
0,762  0,005  Antipsoriatic
0,755  0,005  Antiprotozoal
0,744  0,005  Cholesterol antagonist
0,729  0,005  Antiprotozoal (Plasmodium)
0,732  0,009  Antihypercholesterolemic
0,706  0,005  Nitric oxide antagonist
0,689  0,001  Liver X receptor alpha agonist
0,702  0,018  Antineoplastic (lung cancer)
0,640  0,003  Antiparkinsonian, rigidity relieving
0,610  0,006  Hypolipemic
0,603  0,011  NOS3 expression inhibitor
0,592  0,009  Antineoplastic (brain cancer)
0,601  0,024  Antileukemic
0,586  0,012  Hepatic disorders treatment
0,582  0,015  Immunosuppressant
0,566  0,010  Antiprotozoal (Leishmania)
0,545  0,014  Antifungal
0,529  0,003  Inducible nitric-oxide synthase inhibitor
0,529  0,005  Contraceptive
0,546  0,025  Prostate cancer treatment
0,539  0,021  Carcinogenic
0,534  0,019  Immunomodulator
0,533  0,029  Teratogen
0,535  0,032  Antibacterial
0,521  0,027  Antipruritic, allergic
0,510  0,019  Antioxidant
0,487  0,004  Sodium/bile acid cotransporter inhibitor
0,496  0,028  Antineoplastic (ovarian cancer)
0,474  0,007  Interferon gamma antagonist
0,486  0,020  Proliferative diseases treatment
0,478  0,011  Antineoplastic (renal cancer)
0,460  0,005  Lipocortins synthesis antagonist
0,480  0,027  Cytotoxic
0,468  0,016  UGT2B4 substrate
0,458  0,007  Prostate disorders treatment
0,444  0,008  UGT2B7 substrate
0,468  0,034  Embryotoxic
0,434  0,007  Antipruritic, non-allergic
0,435  0,008  Antiacne
0,406  0,003  Liver X receptor agonist
0,400  0,006  DNA polymerase I inhibitor
0,405  0,012  Prostatic (benign) hyperplasia treatment
0,396  0,005  Interleukin 4 antagonist
0,403  0,015  Abortion inducer
0,460  0,074  Antineoplastic (solid tumors)
0,386  0,005  Neurotrophic factor
0,388  0,017  UGT1A4 substrate
0,406  0,035  Antineoplastic (glioma)
0,371  0,015  Diuretic
0,442  0,087  Caspase 9 stimulant
0,370  0,033  Antineoplastic (glioblastoma multiforme)
0,355  0,022  UGT1A1 substrate
0,337  0,004  Antifungal (Cryptococcus)
0,346  0,014  Hair growth stimulant
0,333  0,003  Hyperparathyroidism treatment
0,334  0,005  Farnesoid X receptor antagonist
0,375  0,046  Apoptosis antagonist
0,346  0,020  Hepatoprotectant
0,403  0,077  TNF expression inhibitor
0,332  0,006  Androgen antagonist
0,332  0,008  Cholesterol synthesis inhibitor
0,331  0,008  Antineoplastic antibiotic
0,358  0,035  Antineoplastic (lymphoma)
0,355  0,050  Antineoplastic (pancreatic cancer)
0,339  0,035  UGT1A6 substrate
0,351  0,061  ICAM1 expression inhibitor
0,300  0,010  UGT2B9 substrate
0,319  0,031  UDP-glucuronosyltransferase substrate
0,316  0,039  Antiparasitic
0,282  0,005  Postmenopausal disorders treatment
0,324  0,050  NOS2 expression inhibitor
0,317  0,043  Angiogenesis stimulant
0,280  0,018  Interleukin 6 antagonist
0,327  0,071  Antihypertensive
0,259  0,004  Hypercalcemia treatment
0,274  0,020  Antiviral (Influenza A)
0,322  0,069  AR expression inhibitor
0,320  0,074  Antineoplastic (colorectal cancer)
0,250  0,005  Pregnane X receptor agonist
0,311  0,066  Interleukin 2 agonist
0,306  0,068  CTGF expression inhibitor
0,309  0,073  Antineoplastic (colon cancer)
0,239  0,005  Interleukin 2 antagonist
0,272  0,038  Antiviral (Influenza)
0,351  0,121  Cyclophilin D inhibitor
0,351  0,121  Antidiabetic
0,286  0,057  Platelet antagonist
0,253  0,025  Liver fibrosis treatment
0,234  0,010  Arachidonic acid antagonist
0,244  0,030  Anesthetic
0,217  0,007  Nitric-oxide synthase inhibitor
0,282  0,078  Antineoplastic (melanoma)
0,232  0,037  Diabetic nephropathy treatment
0,243  0,047  Antihelmintic
0,250  0,062  Interleukin antagonist
0,196  0,013  HDL-cholesterol increasing
0,199  0,020  Microtubule formation inhibitor
0,236  0,057  Anesthetic general
0,254  0,076  Interleukin agonist
0,211  0,034  Skin whitener
0,204  0,034  UGT2B10 substrate
0,203  0,035  Bone formation stimulant
0,208  0,047  UGT1A3 substrate
0,180  0,020  UGT2B1 substrate
0,162  0,003  Vitamin D receptor antagonist
0,231  0,071  Sensitization
0,165  0,010  UGT2B11 substrate
0,159  0,005  Anticholelithogenic
0,253  0,100  Respiratory analeptic
0,168  0,016  Antibiotic
0,184  0,034  Protein-tyrosine phosphatase 1B inhibitor
0,173  0,027  Liver cirrhosis treatment
0,168  0,025  Alcohol dehydrogenase substrate
0,228  0,086  Tumour necrosis factor alpha release inhibitor
0,237  0,095  Chemoprotective
0,165  0,029  Antischistosomal
0,148  0,013  CDC25A inhibitor
0,211  0,077  Antihypertriglyceridemic
0,141  0,008  Na+ K+ transporting ATPase inhibitor
0,165  0,040  Antihyperlipoproteinemic
0,138  0,014  Antiprotozoal activity enhancer
0,142  0,019  Paget's disease treatment
0,153  0,031  Contraceptive female
0,148  0,027  Antiinfertility, female
0,121  0,002  Parathyroid hormone antagonist
0,125  0,008  Acetyl-CoA transferase inhibitor
0,197  0,080  Neurotrophic factor enhancer
0,124  0,011  Glycine receptor agonist
0,172  0,061  Protein-tyrosine phosphatase inhibitor
0,119  0,008  5-Alpha-reductase inhibitor
0,135  0,027  Anabolic
0,216  0,109  UGT1A9 substrate
0,142  0,037  Choleretic
0,200  0,100  Antineoplastic (cervical cancer)
0,160  0,063  UGT2B15 substrate
0,133  0,038  Anticataract
0,156  0,065  Antidiarrheal
0,118  0,031  SULT1E1 substrate
0,100  0,014  Androgen agonist
0,212  0,127  Analeptic
0,086  0,003  HMG CoA reductase inhibitor
0,088  0,005  Acetyl-CoA transferase 1 inhibitor
0,089  0,009  Mineralocorticoid receptor antagonist
0,109  0,032  Bile acid receptor antagonist
0,198  0,121  Immunostimulant
0,112  0,037  Actinic keratosis treatment
0,099  0,025  T cell inhibitor
0,082  0,008  RNA-directed RNA polymerase stimulant
0,214  0,139  Metabolic disease treatment
0,140  0,067  Antifungal enhancer
0,069  0,002  Vitamin D receptor agonist
0,080  0,013  Lipocortins synthesis agonist
0,199  0,135  Renal disease treatment
0,069  0,007  Farnesoid X receptor agonist
0,105  0,044  ABCA1 expression enhancer
0,157  0,097  Toxic, respiratory center
0,091  0,032  SULT1A2 substrate
0,139  0,082  Adenylate cyclase stimulant
0,141  0,085  Acute respiratory distress syndrome (ARDS) treatment
0,116  0,062  Skin irritative effect
0,153  0,101  Phospholipase C inhibitor
0,056  0,005  CYP24 inhibitor
0,193  0,143  Antidiabetic (type 2)
0,091  0,045  Vanilloid agonist
0,054  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,047  0,004  Hedgehog signaling activator
0,059  0,016  Microtubule stabilization
0,116  0,074  Growth stimulant
0,187  0,147  CYP2C19 substrate
0,080  0,042  Antitreponemal
0,099  0,064  Sulfotransferase substrate
0,046  0,015  Cholesterol absorption inhibitor
0,070  0,043  SULT2A1 substrate
0,060  0,034  Postcoital contraceptive
0,025  0,001  Vitamin D-like
0,030  0,007  Progesterone agonist
0,125  0,103  Antiviral (Herpes)
0,177  0,157  Amyotrophic lateral sclerosis treatment
0,031  0,012  1,3-Beta-glucan synthase inhibitor
0,130  0,114  Melanin inhibitor
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,060  0,046  Heme oxygenase stimulant
0,037  0,025  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,023  0,012  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,139  0,128  LDLR expression enhancer
0,154  0,148  Antineoplastic enhancer
0,021  0,015  Corticosteroid-like
0,032  0,027  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,062  0,057  Premenstrual syndrome treatment
0,093  0,090  SULT1A1 substrate
0,018  0,015  Apical sodium codependent bile acid transporter inhibitor
0,080  0,079  ATPase (Vacuolar H+) inhibitor
0,016  0,015  Telomerase stimulant
0,109  0,108  Antihemorrhagic

